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ABSTRACT— As a result of the introduction of fast-track pro-
grams, the length of hospital stay after arthroplasty has decreased 
to a point where some patients meet the discharge criteria on the 
day of surgery. In several studies, well-established fast-track cen-
ters have demonstrated the feasibility of outpatient procedures in 
selected patients. However, in literature the term “outpatient” is 
sometimes also used for patients who spend one or more nights 
in hospital. We therefore propose to use “outpatient” solely for 
patients who are discharged to their own home on the day of 
surgery and do not have an overnight stay at either the hospi-
tal or another non-home facility. Also, several challenges need to 
be overcome before this becomes an established procedure. The 
combination of preoperative high-dose steroids and multimodal 
opioid-sparing analgesia has enhanced patient recovery after 
arthroplasty, but efforts to control undesirable pathophysiologi-
cal responses will be a prerequisite to improve the success rate 
of an outpatient setting. Also, care must be taken to avoid extra 
activities or investments solely to enable discharge on the day of 
surgery. Further cost analyses will have to be performed to estab-
lish the true fi nancial benefi t of outpatient treatment.
■
In the past decades, fast-track programs have successfully been 
introduced in orthopedics, mainly in total hip and knee arthro-
plasty (THA and TKA). Thus, a combination of organizational 
and medical improvements in the pain and anesthetic, mobili-
zation, and surgical protocols has led to enhanced recovery of 
patients after arthroplasty lowering morbidity and mortality.
As a side effect of these programs, length of hospital stay 
(LOS) decreased to a point where a majority of total joint 
arthroplasty (TJA) patients reached the essentially unchanged 
discharge criteria after the fi rst postoperative night (Klapwijk 
et al. 2017). Although some patients reach these criteria on 
the day of surgery, outpatient TJA remains a psychologi-
cal barrier in many institutions; in addition, reimbursement 
issues and concerns over safety prevent surgeons from allow-
ing patients to go home on the day of surgery (Thienpont et 
al. 2015). Until recently, the reports of outpatient TJA have 
mostly been anecdotal, single surgeon or single institution 
based on selected patient populations (Berger et al. 2005, Dorr 
et al. 2010, Aynardi et al. 2014, Hartog et al. 2015, Kort et al. 
2015). However, 2 more recent papers report on a multicenter 
randomized trial (Goyal et al. 2017) and a 2-center study with 
unselected patients (Gromov et al. 2017), confi rming the fea-
sibility of outpatient TJA in unselected populations. However, 
many challenges need to be overcome before it can be defi ned 
as an established treatment option and with more widespread 
recommendations. 
Defi nition of outpatient THA and TKA
Different defi nitions of outpatient arthroplasty are used in 
publications. In some reports a length of stay of < 23 hours is 
defi ned as outpatient (Sher et al. 2017), whereas others defi ne 
outpatient as hospital discharge on the day of surgery (Nelson 
et al. 2017). The National Surgical Quality Improvement Pro-
gram (NSQIP) used in many studies appears not to be a con-
sistent entity. In a study by Bovonratwet et al. (2017) using 
the NSQIP, of the 529 THA patients who were registered as 
outpatients, only 63 (12%) were actually discharged on the 
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day of surgery and of 890 patients undergoing TKA who were 
registered as outpatients, only 95 (11%) were discharged on 
the day of surgery. Current regulations in the United States 
allow for these observed patients to stay more than 1 night in 
hospital under observation status, despite being coded as out-
patients (Bovonratwet et al. 2017). Some studies that report on 
outpatient TJA with data from the NSQIP use the outpatient 
variable, which may include patients who have been admit-
ted for 1 night or more (Lovecchio et al. 2016, Courtney et 
al. 2017), whilst others use the LOS variable, including only 
patients with an LOS of 0 nights (Sher et al. 2017, Nelson et 
al. 2017). Clarity and uniformity is essential in publications 
on outpatient TJA. We would therefore propose to reserve the 
term “outpatient” solely for patients who are discharged to 
their own home on the day of surgery and who do not have 
an overnight stay at either the hospital or another non-home 
facility.
Why in hospital: pathophysiological 
considerations on postoperative recovery
When discussing the possibilities for outpatient TJA, the basic 
question is what the reasons are for “staying in the hospital.” 
There seem to be 3 types of reasons: early organ dysfunc-
tion, appearance of complications, and organizational factors 
(Husted et al. 2011). Among the early organ dysfunctions, 
pain, nausea and vomiting, fatigue, weakness, and dizziness 
are the main complaints. In contrast, a well-implemented fast-
track approach has been demonstrated to decrease the risk of 
thromboembolic complications, cardiopulmonary complica-
tions and mortality, delirium, etc. Furthermore, a fast-track 
approach will attenuate the consequences of the otherwise 
well-established comorbidities (diabetes, cardiopulmonary, 
etc.) as risk factors for hospitalization and complications (Jør-
gensen et al. 2016).
Since a study of unselected patients planned for TJA 
(Gromov et al. 2017) has shown that about 15–20% can be 
managed in an outpatient setting, the main question to be 
answered is: What are the reasons for delayed recovery and 
discharge in the remaining 85%? Obviously, organizational 
issues may account for a proportion of patients in which dis-
charge is delayed. However, as mentioned earlier, the early 
organ dysfunctions leading to a risk of delayed recovery and/
or complications, which are principally mediated by the surgi-
cal stress responses (neuroendocrine/infl ammatory/immuno-
logical), may be the most important determinant for delayed 
recovery in TJA (Gaudilliere et al. 2014). Consequently, the 
possibilities for future enhancement of a successful and safe 
outpatient TJA setting will require interventions to attenuate 
these responses. For this purpose, preoperative high-dose ste-
roids (Jørgensen et al. 2017) in combination with well-estab-
lished multimodal opioid-sparing analgesia are most promis-
ing. Despite these improvements, the future challenges will 
include more attention to specifi c high-risk patient groups 
such as those receiving preoperative opioids, pain catastroph-
izers, and patients receiving psychopharmacological treatment 
(Greene et al. 2016, Jørgensen et al. 2016). Also, the mecha-
nism for the pronounced early loss of quadriceps strength in 
TKA (which may lead to weakness and risk of falling) needs 
to be clarifi ed. Neither surgery without the use of a tourni-
quet nor high-dose steroids have so far solved this problem 
(Lindberg-Larsen et al. 2017). Finally, the well-documented 
patient complaints concerning nausea, dizziness, and risk of 
syncope and falling may be related to early orthostatic intoler-
ance (Jans and Kehlet 2017). Further research is required to 
defi ne the relative role of autonomic nervous system distur-
bances, opioid use, and the infl ammatory response. The risk 
of delirium has essentially been eliminated by the fast-track 
setup (Petersen et al. 2017), but further challenges and need 
for improvement are related to the pronounced early sleep dis-
turbances that also may have an infl uence on subsequent pain 
responses (Chouchou et al. 2014). Finally, the risk of severe 
complications must be differentiated between “medical” and 
direct “surgical” complications, since the fast-track approach 
primarily focuses on improvements in medical morbidity in 
contrast to an initial “surgical” complication (hip dislocation, 
bleeding, etc.), which may be related to surgical expertise 
(Kehlet and Jørgensen 2016). However, the overall risk of 
mortality with the fast-track approach is currently extremely 
low (Jørgensen and Kehlet 2017) and not considered to be a 
relevant safety issue within a potential outpatient setting. In 
summary, efforts to control undesirable pathophysiological 
responses to TJA will be a prerequisite to improve the success 
rate of an outpatient setting. The main challenge remains to 
demonstrate the safety and positive patient recovery aspects 
of an outpatient setting vs. staying until the next day or even a 
little longer in the identifi ed specifi c high-risk patient groups 
already mentioned.
Economic benefi ts of outpatient TJA
In an economically challenged environment like today’s hos-
pital system, the fi nancial burden of an increasing number of 
arthroplasties needs to be addressed. Thus, it has been esti-
mated that the number of hip and knee arthroplasties will 
increase by 75% in the years to come in the US alone (Kurtz et 
al. 2014) and similar projections have been made for Sweden 
(Nemes et al. 2014). 
Fast track has, apart from being clinically superior to more 
conventional pathways and resulting in less morbidity and 
mortality, also been shown to be fi nancially attractive by low-
ering LOS. Thus, very low costs of around US$ 2,500 for a 
2-day stay have been calculated in 2 Danish fast-track depart-
ments using the Time Driven Activity Based Costing method 
(Andreasen et al. 2017). The economic benefi t of outpatient 
TJA is the lower cost associated with the reduced length of 
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stay (Aynardi et al. 2014, Lovald et al. 2014). Also, outpatient 
TJA can be performed in selected healthier patients in Ambula-
tory Surgical Centers (ASC), which may benefi t from reduced 
overhead costs compared with inpatient hospitals (Parcells et 
al. 2016, Klein et al. 2017). However, in inpatient hospitals, 
the reduced cost associated with outpatient treatment is more 
diffi cult to assess. After all, a bed that would normally be used 
for a TJA patient will not always be fi lled with another patient 
on the orthopedic ward on that same night. In contrast, operat-
ing on the outpatient ward/ASC in hospitals that do not have 
any patients or hospital staff in the evening or at night would 
lead to cost reduction.
Attention must, however, also be given to the costs that are 
incurred outside the ASC or the hospital. If, as a consequence 
of discharge on the day of surgery, patients are transferred to 
skilled nursing facilities instead of their own home, if extra 
physical therapy is indicated or if extra home care or home 
visits by nurses or physical therapists are needed, the poten-
tial fi nancial benefi ts for ASCs or hospitals are outweighed 
by the additional activities in the postoperative period. Also, 
if discharge on the day of surgery leads to more readmissions 
or complications the potential fi nancial benefi ts are nulli-
fi ed or worse. Therefore, further cost analyses will have to 
be performed to establish the true fi nancial benefi t of outpa-
tient treatment. Consequently, the primary goal of physicians 
who implement an outpatient program should be to ensure 
patient safety and avoid extra activities or investments that 
are employed solely to enable discharge on the day of surgery 
unless a cost–benefi t analysis is performed beforehand. Alto-
gether, although healthcare budgets are under pressure, cost 
reduction or profi t optimization should not be the main driver 
of outpatient treatment.
Conclusions
The published studies on outpatient TJA from Europe have all 
been from institutions that have a well-established fast-track 
protocol (Hartog et al. 2015, Kort et al. 2015, Gromov et al. 
2017, Hoorntje et al. 2017). As a result of their programs, these 
hospitals have seen their length of stay gradually decrease to 
a point where outpatient TJA seemed feasible. This requires, 
however, a serious investment in time and resources and with-
out this effort other hospitals should not commence an out-
patient program. For most hospitals, outpatient TJA surgery 
should not be a goal in itself, but should rather be the result of 
a successful, already implemented fast-track program based 
on the concept “fi rst better – then faster.” Only then will it 
not lead to an increased rate of complications and readmis-
sions. Consequently, several challenges lie ahead focusing on 
organizational aspects, improving interventions to reduce the 
risk of organ dysfunction, safety issues, and economic conse-
quences.
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